Nonetheless, we cannot overlook the fact that insulin resistance is the main feature of type II DM and that insulin resistance also occurs in the brain (Athauda and Foltynie, 2016a) with defective insulin signaling being identified as an important player in the pathogenesis of neurodegenerative disorders and particularly Alzheimer’s disease (AD; Steen et al., 2005; Talbot et al., 2012; Freiherr et al., 2013; Arnold et al., 2018). The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.